Skip to main content

Lifeward Ltd.

corporate_fare Company Profile

Lifeward Ltd.

LFWD·NASDAQ·Industrial Applications And Services·CIK 0001607962

ReWalk is a medical device company that designs, develops, and commercializes solutions for physical rehabilitation and recovery. The company's initial product offerings were the ReWalk Personal and ReWalk Rehabilitation Exoskeleton devices, referred to as SCI Products, for individuals with spinal cord injury. These robotic exoskeletons use patented tilt-sensor technology, an onboard computer, and motion sensors to power motorized legs, enabling individuals with paraplegia to stand and walk. In March 2023, ReWalk received 510(k) clearance from the U.S. FDA for the ReWalk Personal Exoskeleton with stair and curb functionality, allowing U.S. users to navigate stairs and curbs. This feature has been available in Europe since initial CE Clearance, supported by real-world data from 47 European users over seven years, involving over 18,000 stair steps. In March 2025, the company received 510(k) clearance for the ReWalk 7 Personal Exoskeleton device, a next-generation model. ReWalk has also expanded its product offerings beyond SCI Products, including the ReStore Exo-Suit device, which began commercialization in June 2019. The ReStore is a powered, lightweight soft exo-suit designed for the rehabilitation of individuals with lower limb disabilities due to stroke. Sales of the ReStore device in the European Union ceased in May 2024.

Lifeward Ltd. (NASDAQ:LFWD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 47 items for LFWD at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Strategic Investors Register Over $50M in Shares for Resale, Creating Massive Overhang for Lifeward Ltd.
  • Lifeward Terminates VP of Strategy Amidst Ongoing Financial Challenges
  • Lifeward Regains Nasdaq Compliance After Audit Committee Appointments
  • Lifeward Ltd. Regains Nasdaq Audit Committee Compliance, Resolving Prior Delisting Threat
  • Lifeward Closes Oramed Acquisition, Issues Highly Dilutive Equity & Notes, Reshapes Board

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$22.03M
Net Income
-$19.91M
Diluted EPS
-$17.16
Op. Cash Flow
-$16.83M
Free Cash Flow
-$16.84M
Gross Profit
$8.43M
Operating Income
-$19.67M
Cash & Equivalents
$2.17M
Debt / Equity
0.00×
Net Margin
-90.4%
Shares Outstanding
1.52M sh
Source: 10-K · filed 2026-03-18 · accession 0001178913-26-001208
$2.8 -4.98% today
52-week range · as of 2026-11-13 $2.8 – $9.61
Market cap
$7.96M
Volume
35.4K (1.7× avg)
3-mo avg 20.7K
Live data · 2026-11-22 12:47 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LFWD - Filings & News (Page 2)

LFWD
Apr 27, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $7.49
Real-time Price: $2.80 info
Change: -$4.69 (-63%) info
Market Cap: $7.957M info
LFWD
Apr 23, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.65
Real-time Price: $2.80 info
Change: -$4.85 (-63%) info
Market Cap: $7.957M info
LFWD
Mar 31, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $6.31
Real-time Price: $2.80 info
Change: -$3.51 (-56%) info
Market Cap: $7.957M info
LFWD
Mar 31, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.31
Real-time Price: $2.80 info
Change: -$3.51 (-56%) info
Market Cap: $7.957M info
LFWD
Mar 25, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.30
Real-time Price: $2.80 info
Change: -$3.50 (-56%) info
Market Cap: $7.957M info
LFWD
Mar 25, 2026, 4:10 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $6.71
Real-time Price: $2.80 info
Change: -$3.91 (-58%) info
Market Cap: $7.957M info
LFWD
Mar 20, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.74
Real-time Price: $2.80 info
Change: -$3.94 (-58%) info
Market Cap: $7.957M info
LFWD
Mar 18, 2026, 11:43 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $6.57
Real-time Price: $2.80 info
Change: -$3.76 (-57%) info
Market Cap: $7.957M info
LFWD
Mar 18, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $7.00
Real-time Price: $2.80 info
Change: -$4.20 (-60%) info
Market Cap: $7.957M info
LFWD
Mar 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $7.00
Real-time Price: $2.80 info
Change: -$4.20 (-60%) info
Market Cap: $7.957M info
LFWD
Mar 13, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.00
Real-time Price: $2.80 info
Change: -$4.20 (-60%) info
Market Cap: $7.957M info
LFWD
Mar 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $6.97
Real-time Price: $2.80 info
Change: -$4.17 (-60%) info
Market Cap: $7.957M info
LFWD
Mar 11, 2026, 8:23 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $6.06
Real-time Price: $2.80 info
Change: -$3.26 (-54%) info
Market Cap: $7.957M info
LFWD
Mar 11, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.40
Real-time Price: $2.80 info
Change: -$3.60 (-56%) info
Market Cap: $7.957M info
LFWD
Mar 03, 2026, 8:55 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $6.78
Real-time Price: $2.80 info
Change: -$3.98 (-59%) info
Market Cap: $7.957M info
LFWD
Mar 02, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.78
Real-time Price: $2.80 info
Change: -$3.98 (-59%) info
Market Cap: $7.957M info
LFWD
Mar 02, 2026, 8:15 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $7.00
Real-time Price: $2.80 info
Change: -$4.20 (-60%) info
Market Cap: $7.957M info
LFWD
Feb 27, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.40
Real-time Price: $2.80 info
Change: -$4.60 (-62%) info
Market Cap: $7.957M info
LFWD
Feb 25, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.02
Real-time Price: $2.80 info
Change: -$3.22 (-53%) info
Market Cap: $7.957M info
LFWD
Feb 19, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.520
Real-time Price: $2.80 info
Change: Reverse Stock Split info
Market Cap: $7.957M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets